SETD2 and nonpapillary renal cell carcinoma: Multiple drivers (i.e., two or more driver gene mutations in PBRM1, SETD2, BAP1 or PTEN in addition to VHL [14]) were found in seven of 17 ccRCC samples (41.2%).